vimarsana.com

Page 5 - மருத்துவ ஆராய்ச்சி தேசிய நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ICMR-NIN launches online survey on nutrition-related web search behaviour

ICMR-NIN launches online survey on nutrition-related web search behaviour There are concerns about the misinformation of pandemic spreading through social media which is termed as infodemic . Share Updated: May 28, 2021, 08:15 PM IST Hyderabad: Internet usage has accelerated among Indians, especially among those following Covid-19 appropriate behaviour such as physical distancing, restrictions on gatherings. Now, there are concerns about the misinformation of pandemic spreading through social media which is termed as infodemic . The Indian Council of Medical Research-National Institute of Nutrition (ICMR-NIN) has launched an e-survey to assess the impact of the abundance and overburden of food and nutrition-related information on the web search behaviour, nutrition-related knowledge, attitude and practices as well as real and perceived food scares among the people during different phases of the COVID19 pandemic.

Turning the COVID-19 tide in Chennai

Virologist Shahid Jameel quits Centre s panel on genome sequencing

Virologist Shahid Jameel quits Centre’s panel on genome sequencing Last week, Jameel had written a piece on the second wave of coronavirus in the New York Times . By PTI|   Published: 17th May 2021 1:40 pm IST Noted virologist Dr Shahid Jameel (Photo: commons.wikimedia.org) New Delhi: Days after pointing out that scientists are facing “stubborn resistance to evidence-based policy making”, noted virologist Shahid Jameel quit as the head of INSACOG, a central government panel which conducts genome sequencing of coronavirus. Jameel announced his plan to step down in a meeting of INSACOG held on Friday, said two officials who were part of it.

Covaxin effectively neutralises all key emerging variants, says study published in Oxford journal | India News

HYDERABAD: Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first identified in India and the UK, its developer Bharat Biotech said on Sunday. A top official of the company also said that no difference in neutralisation was observed between B.1.1.7 (first isolated in the UK) and vaccine strain (D614G) that was used to develop Covaxin. Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, Bharat Biotech joint managing director Suchitra Ella tweeted: “A modest reduction in neutralisation by a factor of 1.95 was observed against B.1.617 variant compared to the vaccine variant (D614G). Despite this reduction, neutralising titre levels with B.1.617 remain above levels expected to be protective.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.